These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19647487)

  • 41. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
    Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
    Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intra-arterial thrombolysis of complete deep cerebral venous thrombosis.
    Liebetrau M; Mayer TE; Bruning R; Opherk C; Hamann GF
    Neurology; 2004 Dec; 63(12):2444-5. PubMed ID: 15623729
    [No Abstract]   [Full Text] [Related]  

  • 43. [Quicker thrombolytic treatment in stroke?].
    Johnsen SH
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2213. PubMed ID: 19898566
    [No Abstract]   [Full Text] [Related]  

  • 44. Intravenous thrombolysis.
    Nguyen TH; Truong AT; Ngo MB; Bui CT; Dinh QV; Doan TC; Nguyen LT; Phan TC; Phan MV; Nguyen TV; Le TV
    Int J Stroke; 2010 Dec; 5(6):516. PubMed ID: 21050414
    [No Abstract]   [Full Text] [Related]  

  • 45. Thrombolysis in very young children.
    Bhatt A
    Stroke; 2009 Oct; 40(10):e596; author reply e597. PubMed ID: 19696425
    [No Abstract]   [Full Text] [Related]  

  • 46. How many patients might receive thrombolytic therapy in the light of the ECASS-3 and IST-3 data?
    Bembenek J; Kobayashi A; Sandercock P; Czlonkowska A
    Int J Stroke; 2010 Oct; 5(5):430-1. PubMed ID: 20854633
    [No Abstract]   [Full Text] [Related]  

  • 47. Neck hematoma after intravenous thrombolysis for stroke treatment.
    Fonseca AC; Geraldes R; Reimão S; Pinho e Melo T; Ferro JM
    Cerebrovasc Dis; 2010; 30(1):101-2. PubMed ID: 20501994
    [No Abstract]   [Full Text] [Related]  

  • 48. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
    Schellinger PD; Köhrmann M
    Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
    [No Abstract]   [Full Text] [Related]  

  • 49. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
    Wechsler LR
    Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
    [No Abstract]   [Full Text] [Related]  

  • 50. The gender effect in stroke thrombolysis: of CASES, controls, and treatment-effect modification.
    Kent DM; Buchan AM; Hill MD
    Neurology; 2008 Sep; 71(14):1080-3. PubMed ID: 18495951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra-arterial thrombolytic therapy for acute stroke: the debate continues.
    Tong DD
    Stroke; 2002 Jul; 33(7):1827. PubMed ID: 12109492
    [No Abstract]   [Full Text] [Related]  

  • 52. Medical therapy for ischemic stroke: review of intravenous and intra-arterial treatment options.
    Taussky P; Tawk RG; Daugherty WP; Hanel RA
    World Neurosurg; 2011 Dec; 76(6 Suppl):S9-15. PubMed ID: 22182278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Thrombolysis in acute ischemic stroke with intravenous recombinant tissue-type plasminogen activator].
    May Z; Kakuk I; Ováry C; Ricsóy G; Skopál J; Szegedi N; Varga D; Nagy Z
    Orv Hetil; 2002 Nov; 143(44):2479-84. PubMed ID: 12674802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.
    Katzan IL; Sila CA; Furlan AJ
    Stroke; 2001 Apr; 32(4):861-5. PubMed ID: 11283383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombolysis 2004: the good, the bad, and the ugly.
    Caplan LR
    Rev Neurol Dis; 2004; 1(1):16-26. PubMed ID: 16397447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induced hypertension in patients with partial recanalization after intra-arterial thrombolysis for acute ischemic stroke.
    Shah QA; Patel S; Qureshi AI
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):154-5. PubMed ID: 18362784
    [No Abstract]   [Full Text] [Related]  

  • 58. Bolus-to-Infusion Time in Stroke Patients Treated with Alteplase on the CT Table: A Clinical Concern.
    Iglesias Mohedano AM; García Pastor A; de Lorenzo Pinto A; Gil Núñez AC
    Cerebrovasc Dis; 2019; 48(1-2):96-98. PubMed ID: 31593952
    [No Abstract]   [Full Text] [Related]  

  • 59. [The future perspective of acute thrombolytic therapy for acute ischemic stroke].
    Matsuki T; Toyoda K
    Nihon Rinsho; 2016 Apr; 74(4):613-20. PubMed ID: 27333749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
    Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
    Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.